March 24, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Updated guidance from ACP revealed the best practices for treating confirmed cases of COVID-19 in an outpatient setting, including the use of medications. Amir Qaseem, MD, PhD, MHA, MGIN, MRCP, FACP, ACP’s chief science officer and senior vice president of clinical policy at the Centers for Evidence Reviews, and colleagues published the recommendations in Annals of Internal Medicine.
March 24, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

ACP has published living clinical guidance to help physicians select medications for patients with overweight or…

CHICAGO — Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced…

ORLANDO — In patients newly diagnosed with Mycobacterium avium complex lung disease, amikacin liposome inhalation suspension…

Early and aggressive intervention is recommended for children with juvenile idiopathic arthritis, according to new 2026…

Clinicians should carefully monitor patients with inflammatory bowel disease and comorbid Clostridioides difficile infection,…

An update to the previously published multispeciality guide for the management of diabetes, cardiorenal and metabolic diseases…